Reneo Pharmaceuticals Announces Notice of Allowance for Patent Application on REN001
IRVINE, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on...
Day: October 14, 2021
Pasithea Therapeutics Opens its First Ketamine Therapy Clinic in the United Kingdom
-- Pasithea Clinics partners with ZEN Healthcare – a network of health clinics in Central London – to offer ketamine...
Evaxion Biotech Wins Frost & Sullivan 2021 Enabling Technology Leadership Award
Recognizes achievements in AI-enabled drug discoveryHighlights how Evaxion’s platforms help to design novel immunotherapies efficientlyCOPENHAGEN, Denmark, Oct. 14, 2021 (GLOBE...
Windtree Hosting Key Opinion Leader Webinar on Istaroxime for the Treatment of Acute Heart Failure and the Upcoming Data in Early Cardiogenic Shock
Tuesday, October 19th @ 8:00 am Eastern TimeWARRINGTON, Pa., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT),...
Mindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the COPE Program with InterVivo Solutions
TORONTO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Plus Therapeutics to Announce Third Quarter 2021 Financial Results and Host Conference Call on October 21, 2021
AUSTIN, Texas, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative,...
Stephen Ross, M.D., Chair of Reset Pharma’s Scientific Advisory Board to Deliver Keynote Presentation at The End in Mind Virtual Conference
NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma) announced today that Stephen Ross, M.D., Chair...
Repligen to Report Third Quarter 2021 Financial Results
Webcast and Conference Call to Be Held Thursday, October 28, 2021 at 8:30 a.m. EDT WALTHAM, Mass., Oct. 14, 2021...
CRISPR Therapeutics Announces Transition of Chief Financial Officer
ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and...
XORTX to Present at the LD Micro Main Event
Virtual Corporate Presentation – October 14, 2021 – 10 am ETCALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics...
Global WholeHealth Partners Corp. (OTC: GWHP), is Approved to Sell Through Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021; Global’s Newly Designed Tests Are Now Ready for the Launch into the Retail Marketplace
Global WholeHealth Partners Corp. (OTC: GWHP) is Now Funded for Growth, Sales, and Expansion from EMC2 Funding. Global is Presenting...
HOOKIPA announces publication on the benefits of its novel arenaviral immunotherapeutics in cancer in Frontiers in Oncology
Comprehensive review highlights potential of HOOKIPA’s versatile arenavirus platform as a new immunotherapy strategy to address critical unmet needs in...
ASLAN Pharmaceuticals Announces Expansion of Scientific Advisory Board With Appointment of Leading Global Experts in Dermatology and Immunology
MENLO PARK, Calif. and SINGAPORE, Oct. 14, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company...
Krystal Biotech Announces Virtual Presentation of Pre-clinical Data on KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency at ESGCT
PITTSBURGH, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for...
Teleflex Announces Third Quarter 2021 Earnings Conference Call Information
WAYNE, Pa., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third...
HEXO to speak at MJBizCon 2021
OTTAWA, Oct. 14, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NASDAQ: HEXO) today announced that...
Faraday Pharmaceuticals Announces First Patient Enrolled in Phase 2 Study for ICU-Acquired Weakness
Expands the potential therapeutic use of FDY-5301SEATTLE, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a biopharmaceutical company dedicated...
Agra Ventures Subsidiary Farmako Launches New THC and CBD Testkit to German Pharmacies
The Proprietary Testkits Perform Identity Testing of Both THC and CBD in Cannabis ProductsVANCOUVER, British Columbia, Oct. 14, 2021 (GLOBE...
Chr. Hansen Annual Report 2020/21
Company announcement no. 10 A year of transition Statement by CEO Mauricio Graber: “Our performance of 7% organic growth and...
